Doctors Revision

Neonatal Respiratory Distress and Respiratory Distress Syndrome: Diagnosis and Management

Text size
On this page

1 Overview

Respiratory distress in the newborn is one of the most common reasons for admission to a neonatal unit: tachypnoea, grunting, retractions and cyanosis signal that the infant is struggling to oxygenate and ventilate. It is a syndrome, not a single diagnosis — the causes range from the benign and self-limiting (transient tachypnoea of the newborn) to surfactant deficiency (respiratory distress syndrome, RDS), infection, meconium aspiration and structural disease. RDS is the archetypal disease of prematurity — the direct result of immature lungs unable to manufacture enough surfactant — and its management (antenatal corticosteroids, continuous positive airway pressure and exogenous surfactant) is among the most successful stories in modern neonatology.

Effective care rests on three habits: recognising distress early with a structured severity score, identifying the cause quickly enough to treat the treatable (especially sepsis), and matching respiratory support to severity while protecting the developing lung.

2 Learning Objectives

  • Explain how surfactant deficiency produces the clinical and radiological picture of RDS.
  • Identify risk factors for RDS and apply antenatal preventive strategies.
  • Recognise respiratory distress clinically and grade its severity.
  • Differentiate RDS from transient tachypnoea, sepsis, meconium aspiration and cardiac disease using history, examination and targeted investigations.
  • Outline stepwise management from CPAP to surfactant to mechanical ventilation, and the complications of each level of support.

3 Surfactant and the Pathophysiology of RDS

Pulmonary surfactant is a phospholipid–protein mixture (dominated by dipalmitoylphosphatidylcholine, DPPC) produced by type II pneumocytes. It lowers surface tension at the air–liquid interface of the alveolus, preventing collapse at end-expiration. Surfactant synthesis matures late in gestation — roughly from 28–34 weeks — which is why RDS tracks prematurity so closely.

When surfactant is deficient:

  1. Surface tension rises and alveoli collapse at end-expiration (atelectasis), reducing functional residual capacity.
  2. Perfusion continues through atelectatic, underventilated units, creating ventilation–perfusion mismatch and right-to-left shunting through the collapsed lung and the patent ductus arteriosus.
  3. The infant must generate ever larger negative pressures to reopen alveoli each breath → increased work of breathing → muscle fatigue.
  4. Protein-rich oedema leaks into alveoli (a hyaline membrane of fibrin and cellular debris lines the alveolar walls) → further gas-exchange failure.
  5. Hypoxia and acidosis perpetuate pulmonary vasoconstriction, worsening the shunt.

4 Risk Factors and Prevention

Major risk factors for RDS

  • Prematurity — the dominant risk; incidence rises steeply below 34 weeks and dramatically below 28.
  • Maternal diabetes — fetal hyperinsulinaemia antagonises surfactant production even at term (higher lecithin:sphingomyelin ratios required).
  • Caesarean delivery without labour — absent labour deprives the fetus of the catecholamine surge that matures surfactant; particularly relevant for late-preterm/early-term elective caesareans.
  • Male sex, multiple gestation, asphyxia, previous affected sibling — modest additional risks.

Prevention

  • Antenatal corticosteroids — betamethasone or dexamethasone to the mother when preterm delivery is anticipated before 34 weeks accelerates fetal lung maturity, reducing RDS, neonatal death and intraventricular haemorrhage. A full course is two doses 24 hours apart; benefit persists and even a partial course helps.
  • Avoiding elective caesarean before 39 weeks where possible, or giving steroids if delivery before 37+6 is unavoidable.
  • Genetic and biochemical lung maturity (lecithin:sphingomyelin ratio ≥2, phosphatidylglycerol present) can guide timing of elective delivery where available.

5 Clinical Features

RDS typically declares itself within minutes to a few hours of birth and worsens over the first 24–72 hours before improving with natural surfactant production (the classic “worst on day 2, better by day 4” course).

Scroll the table sideways on a smaller screen.

SignMechanismClinical note
Tachypnoea (>60 breaths/min)Compensation for reduced tidal volume and V/Q mismatchThe most sensitive early sign; count for a full minute
GruntingPartial glottic closure prolonging expiration, generating end-expiratory pressure to splint alveoliA sign of severe disease; do not mistake it for a chest sound
Nasal flaringReduces upper airway resistanceEarly, subtle sign in small infants
Intercostal/subcostal/sternal retractionsHighly compliant chest wall drawn in against strong diaphragmatic effortSevere retractions indicate high work of breathing and impending fatigue
CyanosisRight-to-left shunt and V/Q mismatchCentral cyanosis needs immediate oxygen; check with pulse oximetry
Poor feeding, lethargy, apnoeasHypoxia and exhaustionApnoeas in a distressed preterm infant demand urgent escalation

Severity is graded with scores such as the Downes score or the Silverman–Andersen respiratory severity score (intercostal, subcostal and sternal retractions, grunting, flaring, air entry), which also guide escalation of respiratory support.

6 Investigations

  • Pulse oximetry — continuous monitoring; pre-ductal (right hand) vs post-ductal targets help detect ductal shunting.
  • Arterial/capillary blood gas — hypoxaemia, hypercarbia, and the mixed respiratory–metabolic acidosis of severe disease; guides ventilation and surfactant thresholds.
  • Chest radiograph — the key confirmatory test for RDS: diffuse ground-glass/reticulogranular shadowing, air bronchograms and low lung volumes. Compare with the alternatives: TTN shows prominent perihilar streaking, fluid fissures and normal/expanded volumes; meconium aspiration shows patchy coarse opacities with hyperinflation; pneumonia shows lobar consolidation; diaphragmatic hernia shows bowel gas in the chest and a mediastinal shift.
  • Bedside ultrasound — increasingly used where available: RDS shows lung hypoechogenicity and abolished aeration with pleural-line abnormalities.
  • Full blood count, CRP, blood culture — sepsis and pneumonia mimic RDS so closely that a septic work-up (and usually empiric antibiotics) accompanies severe respiratory distress in the first days of life.
  • Bedside glucose, calcium — hypoglycaemia and hypocalcaemia both depress respiratory drive and muscle function.

7 Differential Diagnosis

Scroll the table sideways on a smaller screen.

DiagnosisCluesChest X-ray
Transient tachypnoea of the newborn (TTN)Term/near-term, caesarean delivery; tachypnoea from birth, mild, improves over 24–72 hProminent perihilar streaking, fluid in fissures, normal volumes
Neonatal sepsis/pneumoniaRisk factors (prolonged rupture of membranes, chorioamnionitis), temperature instability, shockPatchy/lobar consolidation or diffuse changes indistinguishable from RDS
Meconium aspiration syndromePost-term, meconium-stained liquor; may need high pressures/ventilationHyperinflation with coarse patchy opacities; pneumothorax risk
Congenital diaphragmatic herniaScaphoid abdomen, respiratory distress from birth, absent breath sounds on one sideBowel gas shadows in the hemithorax, mediastinal shift; avoid bag-mask ventilation — intubate
Cyanotic congenital heart diseaseCyanosis out of proportion to respiratory effort; single/diffuse murmur, differential saturationsVariable (boot-shaped in TOF); obtain echocardiography
PneumothoraxSudden deterioration, asymmetric breath sounds, shifted mediastinumVisceral pleural line, absent markings, mediastinal shift — may need emergency needle decompression
Airway obstruction (choanal atresia, Pierre Robin)Stridor/cycle of cyanosis relieved by airway manoeuvresUsually normal; cannulate/definitive airway

8 Management

General supportive care (all infants)

  • Thermal care — neutral-thermal-environment incubator or radiant warmer; cold stress consumes oxygen and glucose.
  • Nutrition and fluids — IV fluids if unable to feed; trophic feeds as tolerated. Strict fluid balance.
  • Monitoring — continuous SpO₂, heart rate, respiratory rate, temperature; frequent blood gases.
  • Minimal handling — procedures cluster to reduce oxygen desaturation and intraventricular haemorrhage risk.

Respiratory support — a stepwise ladder

  1. Oxygen — targeted SpO₂ ranges (typically 90–95% for preterm infants); avoid both hypoxia and hyperoxia (the latter worsens ROP and lung injury).
  2. Nasal continuous positive airway pressure (nCPAP) — the first-line support for spontaneously breathing preterm infants with RDS. PEEP (typically 5–6 cm H₂O) splints alveoli open, improving FRC and reducing work of breathing. Start early — CPAP from birth in at-risk preterm infants reduces surfactant need and intubation.
  3. Surfactant replacement — natural or synthetic surfactant given intratracheally when RDS is confirmed/severe, or prophylactically in very immature infants. Administration techniques include INSURE (INtubate–SURfactant–Extubate to CPAP) and the less-invasive LISA/MIST (thin-catheter administration in a spontaneously breathing infant), which avoids intubation where expertise exists. Repeat dosing is guided by response and FiO₂ needs.
  4. Mechanical ventilation — for apnoea, exhaustion, severe acidosis/hypercarbia, or failure of CPAP + surfactant. Lung-protective settings: low tidal volumes, adequate PEEP, permissive hypercapnia within limits.
  5. High-flow nasal cannula — an intermediate, weaning-step option where CPAP systems are limited.

Pharmacological and adjunctive measures

  • Empiric antibiotics (ampicillin + gentamicin) until sepsis is excluded.
  • Caffeine citrate — for apnoeas of prematurity complicating RDS.
  • Cautious fluids and inotropes — if pulmonary hypertension/shock coexists.

Resource-limited settings: bubble CPAP built from local equipment has transformed RDS survival where ventilators and surfactant are scarce; prioritise early CPAP, oxygen with pulse-oximetry targets, warmth, infection control and safe transport, and refer early for surfactant when available.

9 Complications of RDS and Its Treatment

Scroll the table sideways on a smaller screen.

ComplicationNotes
Air leaksPneumothorax, pneumomediastinum, pulmonary interstitial emphysema — higher with vigorous positive-pressure ventilation
Bronchopulmonary dysplasia (BPD)Chronic lung disease of prematurity — oxygen/ventilator dependence at 36 weeks corrected age; the main long-term respiratory legacy
Patent ductus arteriosusShunt worsens RDS and prolongs ventilation; may need medical (ibuprofen/indomethacin) or surgical closure
Intraventricular haemorrhage (IVH)Fluctuating cerebral blood flow and hypoxia predispose in very preterm infants; grade III–IV carries neurological risk
Retinopathy of prematurity (ROP)Excess oxygen exposure is a key driver; strict SpO₂ targets and screening protect vision
Nosocomial infectionLong lines, ventilation and immaturity increase sepsis risk
Neurodevelopmental impairmentRisk tracks with extreme prematurity and severity of illness, compounded by IVH and hypoxia

10 Prognosis and Long-Term Care

With antenatal steroids, early CPAP and surfactant, survival for infants above 28 weeks’ gestation with RDS is excellent, and most survivors recover fully. Mortality and morbidity rise steeply below 26–28 weeks. Long-term follow-up addresses bronchopulmonary dysplasia (oxygen, diuretics, inhaled steroids as needed), nutrition and growth, developmental surveillance with corrected age for prematurity, ROP screening, and hearing screens. Parents need practical education on infection avoidance, immunisation and recognising respiratory deterioration, plus psychological support after what is often a traumatic start.

11 Viva & Exam Points

  • Definition — RDS = surfactant deficiency → micro-atelectasis, V/Q mismatch and hyaline membranes; the disease of prematurity.
  • Clinical tetrad — tachypnoea >60/min, grunting, nasal flaring, retractions, within hours of birth.
  • Chest X-ray — ground-glass, air bronchograms, low volumes; contrast TTN (streaking, normal volumes).
  • Prevention — antenatal corticosteroids before 34 weeks; avoid elective caesarean before 39 weeks.
  • Management ladder — oxygen → CPAP → surfactant (INSURE/LISA) → mechanical ventilation.
  • Sepsis rule — culture and empiric antibiotics for any infant needing significant support.
  • Complications — air leaks, BPD, PDA, IVH, ROP; strict oxygen targets protect the eyes.

12 References

For education only. Apply current Uganda Clinical Guidelines and local protocols when managing patients.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top